These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 9723235

  • 1. A critical appraisal of cyclosporine A pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (Neoral).
    Foradori A, Pinto VM, Elberg A.
    Transplant Proc; 1998 Aug; 30(5):1666-7. PubMed ID: 9723235
    [No Abstract] [Full Text] [Related]

  • 2. Improvement of correlation between oral dose of cyclosporine and cyclosporinemia after substitution of cyclosporine standard presentation by cyclosporine microemulsion one, in 1345 patients with kidney transplantation. Spanish Sandimmune Neoral Conversion Group.
    Gentil Govantes MA, Gómez Ullate P, Errasti P, Fernández Fresnedo G, Capdevila L, Sanz Guajardo A, Cubero JJ.
    Transplant Proc; 1998 Aug; 30(5):1658-9. PubMed ID: 9723231
    [No Abstract] [Full Text] [Related]

  • 3. Abbreviated AUC strategy for monitoring cyclosporine microemulsion therapy in the immediate posttransplant period.
    Amante AJ, Kahan BD.
    Transplant Proc; 1996 Aug; 28(4):2162-3. PubMed ID: 8769187
    [No Abstract] [Full Text] [Related]

  • 4. Optimization of cyclosporine therapy in kidney transplantation.
    Remuzzi G, Perico N, Gaspari F.
    Transplant Proc; 1998 Aug; 30(5):1673-6. PubMed ID: 9723238
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cyclosporine neoral pharmacokinetics in kidney and heart transplant patients.
    Schiavelli R, Sgrosso JL, Sabbatiello R, Castro C, Ahualli L, Pattin M, Vazquez MC.
    Transplant Proc; 1996 Dec; 28(6):3343-4. PubMed ID: 8962299
    [No Abstract] [Full Text] [Related]

  • 11. Abbreviating area under the curves further: a practical approach to monitoring extended pharmacokinetics with Neoral.
    Sindhi R, Shah J, Foley L, Bucsis J, Kyryliuk T, Baliga PK, Rajagopalan PR.
    Transplant Proc; 1998 Jun; 30(4):1197-8. PubMed ID: 9636485
    [No Abstract] [Full Text] [Related]

  • 12. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.
    Holmberg C, Laine J, Jalanko H, Leijala M, Hoppu K.
    Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219
    [No Abstract] [Full Text] [Related]

  • 13. Sandimmun and Neoral treatment: pharmacokinetics and kidney function in paediatric and adolescent renal transplant.
    De Palma MT, Giordano M, Colella V, Palumbo F, De Nicolo VE, Caringella DA.
    Transplant Proc; 1998 Aug; 30(5):1677. PubMed ID: 9723239
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sandimmun-to-Neoral conversion in stable pediatric kidney transplant recipients.
    Kelles A, Herman J, Tjandra-Maga TB, Van Damme-Lombaerts R.
    Transplant Proc; 1998 Aug; 30(5):1995-6. PubMed ID: 9723366
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and renal function after conversion from standard to microemulsion formulation of cyclosporine in stable renal transplant patients.
    Gaspari F, Anedda MF, Signorini O, Amuchastegui SC, Perico N, Remuzzi G.
    Transplant Proc; 1998 Aug; 30(5):1654-5. PubMed ID: 9723229
    [No Abstract] [Full Text] [Related]

  • 17. Convenience of level of cyclosporine-Neoral at time 3 to determine the area under curve in renal transplant.
    Rial MC, Frias S, Argento J, Tessler J, Casadei D.
    Transplant Proc; 1997 Aug; 29(1-2):292-3. PubMed ID: 9123001
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic analysis of Neoral conversion in pediatric and adult renal transplant recipients with poor absorption of Sandimmune.
    Pescovitz MD, Henson S, Bodziak K, Book BK, Gonin J, Jindal RM, Leapman SB, Milgrom ML, Filo RS.
    Transplant Proc; 1996 Aug; 28(4):2165-8. PubMed ID: 8769189
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic study of twice vs thrice daily dosing of Sandimmun Neoral in pediatric renal transplant patients.
    Papachristou F, Gakis D, Sotiriou I, Liatsis I, Takoudas D, Antoniadis A.
    Transplant Proc; 1998 Aug; 30(5):1988-90. PubMed ID: 9723363
    [No Abstract] [Full Text] [Related]

  • 20. Excessive cyclosporine trough level variation with classic cyclosporine can be reduced with the new oral microemulsion formulation of cyclosporine.
    Bökenkamp A, Offner G, Hoyer PF, Wonigeit K, Brodehl J.
    Transplant Proc; 1996 Aug; 28(4):2273-5. PubMed ID: 8769223
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.